GORDON KEVIN K 4

What Happened

• Kevin K. Gordon, a director of Progyny, sold 5,500 shares in an open-market transaction on 2026-05-27 at $24.99 per share for proceeds of $137,445.
• On the same day he recorded two non‑cash transfers of 2,526 shares each (reported at $0.00): one disposition and one acquisition. Footnotes indicate these shares were transferred between Kevin Gordon personally and the Kevin Gordon Revocable Declaration of Trust U/A/D 9/3/2013, for which he serves as trustee.
• The open‑market sale is a liquidation (not a purchase); the zero‑price entries reflect internal transfers, not market sales or purchases.

Key Details

• Transaction date: 2026-05-27; filing date: 2026-05-29. Open‑market sale price: $24.99; sale proceeds: $137,445.
• Transfers: two entries of 2,526 shares at $0.00 tied to transfers to/from his revocable trust (see footnotes F1–F3).
• Shares owned after the transactions: not specified in the provided Form 4.
• Footnotes: F1/F3 confirm the trust holds the reportable securities and that Gordon is the trustee; F2 notes shares were transferred from the reporting person individually.
• No late filing flag is indicated on the provided filing.

Context

• Transfers into/out of a revocable trust are common estate‑planning moves and do not necessarily reflect a change in insider sentiment. The only market activity here was the 5,500‑share open‑market sale.
• For retail investors, purchases tend to be more informative about confidence; this filing documents a routine sale plus internal transfers.